US 11413309
Compositions and methods for immune cell modulation in adoptive immunotherapies
granted A61KA61K2239/31A61K2239/38
Quick answer
US patent 11413309 (Compositions and methods for immune cell modulation in adoptive immunotherapies) held by Fate Therapeutics, Inc. expires Mon Aug 11 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Fate Therapeutics, Inc.
- Grant date
- Tue Aug 16 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 11 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 26
- CPC classes
- A61K, A61K2239/31, A61K2239/38, A61K31/436, A61K35/28